Week 335 Review - Declines across much of the portfolio

Not a great start to 2022, with some big falls across the portfolio resulting in a drop of £1,282 despite OPTI:Optibiotix staying flat. That extends the deficit between cost and value to £51,586 and reduces total value to £104,014.

The biggest faller was JLP:Jubilee Metals, although that does tend to happen almost every week due to my low purchase price. This week it dropped 11% but is still 254% up.

Next biggest faller is one of my most disappointing recent purchases POLY:Polymetal. It dropped 6% in the SIPP and 8% in the ISA mainly due to political concerns in Ukraine. However, FXPO:Ferrexpo is also in Ukraine and was up this week, so I think it's more that gold miners are just plain out of favour.

TLOU:Tlou Energy is still dropping a worrying amount, this week falling 7% for no clear reason. I'm happy with this as a long term investment, but it's too high risk for me to invest any more, even though it's temptingly cheap right now.

DDDD:4D Pharma continues to be an utter disaster, dropping another 6% this week to go 60% down on my purchase price. Even if it doubles from here I'll still be making a loss. I'm over £10,000 down now, having invested £16,641 making this my second biggest holding by a long way. I can't believe I was daft enough to believe listing on Nasdaq would cause a re-rate upwards, then it's more than halved in value since then.

It's not all doom and gloom this week. It seems the volatile market is helping PLUS:Plus500, which rose by 5% this week and is now only 11% down. Dividends are still rolling in and I don't need to review my holding until the end of May so plenty of time to get back into profit.

Share of the Week is BLU:Blue Star Capital which climbed another 14% as its recovery continues. I am now only 31% down, which compared to the rest of the portfolio isn't bad. Shame I only invested £500. I still think they are a bit rubbish so won't be putting any more in.

Almost flat.

Following the trend line downwards instead of trying to pull it flat.

Here's the ISA and shares portfolio after week 23 of year 7.

			Weekly Change
Cash	£33.30		-£3.75
Portfolio cost	£72,195.21		+£0
Portfolio sell value (bid price-commission)	£48,603.91	(-32.7%)	-£594.04
Potential profits	£2,215.29		-£100
Yr 7 Dividends	£22.16		+£0
Yr 7 Profit from sales	£3,664.29		+£0
Yr 7 projected avg monthly profit	£691.02	(18.8%)	-£32.14
Total Dividends	£1,365.31		+£0
Total Profit from sales	£27,788.23		+£0
Average monthly cash profit	£373.23	(10.1%)	-£1.16
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	65%		+0%

JLP:Jubilee Metals dropped by £100 to dent potential profits, and the rest of the portfolio lost £494. The ISA monthly charge reduced cash.

I so need this to start going up.

Still below the trend line and dragging it steeper.

The SIPP looks like this after week 319 overall and week 7 of year 7.

			Weekly Change
Cash	£316.12		+£86.38
Portfolio cost	£80,422.42		+£0
Portfolio sell value (bid price - commission)	£53,925.59	(-32.9%)	-£640.61
Potential profits	£24.83		-£22.77
Yr 7 Dividends	£51.51		+£0
Yr 7 Interest	£0		+£0
Yr 7 Profit from sales	£381.04		+£0
Yr 7 projected avg monthly profit	£247.03	(6.0%)	-£53.22
Total Dividends	£3,255.90		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£24,105.67		+£0
Average monthly cash profit	£360.06	(8.8%)	-£1.36
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	54%		+0%

Cash went up after a £120 injection to my AJ Bell SIPP which hasn't been invested yet, but the monthly charges were also taken out and I did a bit of a re-set as my adding and subtracting payments must have missed a few lately and it had got out of sync. PAF:Pan African Resources is my only share in profit and that fell this week, so potential profits are a miserable £22. Long term performance is below target so I need my Magic Formula shares to wake up.

Pretty much the same as the ISA.

At least this one is fractionally above the trend line. I doubt this is flattening it much though.

The trading account looks like this after week 285 overall and week 25 of year 6.

			Weekly Change
Cash	£259.74		+£0
Portfolio cost	£2,374.14		+£0
Portfolio sell value (bid price - commission)	£876.02	(-63.1%)	-£47.91
Potential profits	£0.00		+£0
Year 6 Dividends	£0.00		+£0
Year 6 Profit	£0.00		+£0
Yr 6 projected avg monthly profit	£0.00	(0%)	+£0
Dividends	£60.10		+£0
Profit from sales	£937.88		+£0
Average monthly cash profit	£15.17	(7.7%)	-£0.06
(Sold stocks profit + Dividends - Fees / Months)

Good grief. Can this get any worse? Yet another big drop in value largely thanks to DDDD:4D Pharma. I haven't sold anything for a year - what sort of trading account does that? I'm utterly rubbish at it.

Move along please, nothing to see here.

I'm really impressed with how neatly we're following the trend line downwards.

We were expecting news from DDDD:4D Pharma, OPTI:Optibiotix and SBTX:SkinBioTherapeutics before Christmas, but it never appeared. Let's hope it comes soon in 2022 as these shares have the ability to turn around my current desperate performance very quickly, but only when the news hits.